CME Group has appointed Michel Everaert as managing director of OTC solutions. In his new role, Everaert will be responsible for overseeing OTC pre- and post-trade products.
He will report to managing director of OTC products & services, Laurent Paulhac. Everaert is joining the U.S. derivatives and futures exchanges owner and operator from IMEX Group, where he was CIO.
Click here for the release from CME Group.